Istalab 50/500 Tablet is a specialized formulation that combines Sitagliptin Phosphate I.P. at a dosage of 50 mg and Metformin HCL I.P. at 500 mg. This combination is specifically designed for the effective management of type 2 diabetes mellitus in adults. Sitagliptin, a member of the DPP-4 inhibitor class, works by enhancing the body’s ability to regulate insulin secretion in response to elevated blood glucose levels, particularly after meals. Metformin, on the other hand, is a well-established biguanide that primarily reduces glucose production in the liver and improves insulin sensitivity in peripheral tissues, thereby facilitating better glucose uptake by the cells.
The dual action of Sitagliptin and Metformin in Istalab 50/500 Tablet makes it an effective choice for patients who require comprehensive glycemic control. This combination therapy is particularly beneficial for individuals who have not achieved adequate blood sugar levels with Metformin alone or those who are beginning their diabetes treatment journey. By addressing multiple pathways involved in glucose metabolism, Istalab 50/500 Tablet helps patients maintain more stable blood sugar levels, which is crucial for preventing the long-term complications associated with diabetes.
While Istalab 50/500 Tablet is generally well-tolerated, some patients may experience side effects. Common adverse reactions include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort. Other potential side effects may include headache and dizziness. Although rare, serious side effects such as lactic acidosis, a potentially life-threatening condition associated with Metformin, can occur. Patients should be vigilant for symptoms such as unusual fatigue, muscle pain, or difficulty breathing and should seek medical attention if these arise.
For proper storage, Istalab 50/500 Tablet should be kept in a cool, dry environment, away from direct sunlight and moisture. It is essential to store this medication out of reach of children and pets to prevent accidental ingestion.